News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
345 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17849)
Month
January (4450)
February (4428)
March (5683)
April (4545)
May (5703)
June (4805)
July (3912)
August (4762)
September (4260)
October (3860)
November (4837)
December (2683)
Day
1 (5)
2 (321)
3 (345)
4 (310)
5 (394)
6 (122)
7 (3)
8 (3)
9 (242)
10 (360)
11 (259)
12 (398)
13 (145)
14 (4)
15 (16)
16 (326)
17 (318)
18 (251)
19 (262)
20 (127)
21 (4)
22 (5)
23 (228)
24 (302)
25 (222)
26 (289)
27 (144)
28 (1)
29 (3)
30 (42)
31 (252)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
Drug Development
Curium’s Phase 3 ECLIPSE Trial Starts Enrolling Patients
Curium announced it has successfully enrolled and dosed patients in the ECLIPSE Trial.
May 3, 2022
·
2 min read
Hemispherian raises seed funding for novel cancer therapeutics
Hemispherian AS, a Norwegian preclinical pharmaceutical company focused on small molecule cancer therapeutics targeting the DNA damage response, is delighted to announce the closure of its successful seed financing.
May 3, 2022
·
2 min read
Nordic Nanovector: New Publication Highlights Synergistic Potential of CD37-targeted Radioimmunoconjugate Humalutin® in Combination with the PARP-inhibitor Olaparib
Nordic Nanovector ASA announces the publication of two new research papers highlighting approaches to improve the potential therapeutic effect of its novel CD37-targeting radioimmunoconjugate Humalutin® in B-cell malignancies, such as Non-Hodgkin Lymphoma.
May 3, 2022
·
6 min read
Business
HAYA Therapeutics Announces Funding from Swiss Innovation Agency Supporting Research Collaborations for Long Non-Coding RNA Therapies
HAYA Therapeutics, SA announced that Innosuisse, the Swiss Innovation Agency, is supporting two research collaboration projects between HAYA and the University of Bern, University Hospital of Bern and Lausanne University Hospital.
May 3, 2022
·
4 min read
Biotech Beach
Agendia Demonstrates Accessibility and Affordability of MammaPrint® and BluePrint® in Europe at ESMO Breast Cancer 2022
Agendia, Inc. announced that it will present new data at the European Society for Medical Oncology Breast Cancer Congress 2022 taking place in Berlin, Germany on May 3-5, 2022.
May 3, 2022
·
6 min read
BioForest
Tubulis Closes €60 Million Series B Financing to Accelerate its ADC Pipeline and Expand its Breadth of Platform Technologies
May 3, 2022 09:00 UTC Tubulis announced the successful completion of a €60 million Series B financing led by Andera Partners with participation from new investors Evotec and Fund+.
May 3, 2022
·
11 min read
Lunaphore deploys COMET™ at Propath UK
Lunaphore, a Swiss life sciences company developing technologies to enable spatial biology in every laboratory, announced that it has deployed its COMET™ PA instrument at Propath UK, one of Europe’s leading contract research organizations.
May 3, 2022
·
4 min read
Drug Development
NanOlogy Publishes Results from a Phase 1/2 Clinical Trial of its Topical Investigational Drug in the Treatment of Cutaneous Metastases of Breast Cancer
NanOlogy LLC, a clinical-stage interventional oncology drug company, announced that results from a clinical trial of topical submicron particle paclitaxel in cutaneous metastases of breast cancer have been published in Breast Cancer Research and Treatment.
May 3, 2022
·
4 min read
Orthostatic Hypotension Market: The Hospitals Segment is Expected to Register Significant Growth
Albany NY, United States: Orthostatic hypotension is also called postural hypotension. It occurs when a patient’s blood pressure decreases while standing up or sitting down.
May 3, 2022
·
5 min read
Philips at ESOC 2022: showcasing integrated solutions across the stroke care pathway
Royal Philips, a global leader in health technology, will showcase its latest advances in its integrated suite of solutions for the treatment of stroke patients at the 2022 European Stroke Organisation Conference.
May 3, 2022
·
7 min read
Previous
8 of 35
Next